LigaChem Biosciences secures $357 million from Korea National Growth Fund, marking the first direct investment in the biotech sector aimed at enhancing its global competitiveness.
Amount Raised
$357 Million
Round Type
Post-IPO Equity
DaejeonBiotechnologyHealth CareTherapeuticsInvestors
Description
LigaChem Biosciences has raised $357 million from the Korea National Growth Fund in a historic investment for the biotech sector. This is the first time the sovereign fund has invested directly in a publicly listed biotech company. The funding is aimed at strengthening LigaChem’s capabilities in oncology therapeutics. This move indicates a shift in national funding strategies towards deep science commercialization.
Quick answer
LigaChem Biosciences raised $357 Million in a Post-IPO Equity round, dated July 4, 2026. Investors: Korea National Growth Fund. LigaChem Biosciences is based in Daejeon, Daejeon, South Korea.
- How much did LigaChem Biosciences raise?
- LigaChem Biosciences raised $357 Million in a Post-IPO Equity round on July 4, 2026.
- Who invested in LigaChem Biosciences?
- Korea National Growth Fund is named as investors in this round.
- What does LigaChem Biosciences do?
- LigaChem Biosciences is dedicated to the discovery and development of innovative therapies that leverage the power of antibody-drug conjugates to treat cancer and other serious diseases.
- Where is LigaChem Biosciences based and how big is it?
- LigaChem Biosciences is based in Daejeon, Daejeon, South Korea. Fundz records about 170 employees.
- Who are the decision-makers at LigaChem Biosciences?
- Fundz holds 1 contact at LigaChem Biosciences, including the CTO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as LigaChem Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Abcuro raised $66M (Series D) on August 18, 2026.
- bioAffinity Technologies raised $4M (Post-IPO Equity) on August 14, 2026.
- Apollomics raised $10M on August 14, 2026.
- Khartis Therapeutics raised $50M (Series B) on August 13, 2026.
- Amplifica Holdings Group raised $26M (Series B) on August 12, 2026.
- InduPro raised $77M (Series B) on August 12, 2026.
Who to call at LigaChem Biosciences, and when
A new round usually means LigaChem Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LigaChem Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LigaChem Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LigaChem Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LigaChem Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
LigaChem Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.